LENSAR, Inc.
LENSAR, Inc. scores highest on Torque (76) and lowest on Price (34). Its PosiPenta is 48.65 out of 100, around the middle of similar companies.
On the Penta Grid this week, LENSAR, Inc. is Grid #306 of 837 in the Healthcare sector in United States, and Grid #2,033 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| LENSAR, Inc. | 48.65 | 34 | 40 | 39 | 76 | 54 |
| Citius Oncology, Inc. | 41.57 | 29 | 62 | 41 | 31 | 45 |
| Telomir Pharmaceuticals, Inc. | 39.98 | 4 | 58 | 55 | 40 | 43 |
| Pelthos Therapeutics Inc. | 29.18 | 0 | 37 | 45 | 20 | 44 |
| CareCloud, Inc. | 50.82 | 35 | 87 | 38 | 49 | 45 |
| Acrivon Therapeutics, Inc. | 42.54 | 42 | 32 | 43 | 54 | 42 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 32.22 |
| P/B ratio | 4.78 |
EEarnings
| Trailing EPS | ₹17.05 |
| Forward EPS | ₹-48.30 |
NNitro
| Price | 549.35 |
| 52-week high | 1225.61 |
| 52-week low | 468.84 |
| Fall from 52-week high | 55.2% |
TTorque
| Return on equity (ROE) | 357.30% |
| Debt-to-equity | 0.08 |
AAnchor
| Beta (price swings) | 0.95 |
| Market cap | ₹674 Cr |
| Insider holding | 21.52% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is LENSAR, Inc.'s PosiPenta score?
LENSAR, Inc.'s PosiPenta is 48.65 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does LENSAR, Inc. stand on the Penta Grid?
On the Penta Grid this week, LENSAR, Inc. is Grid #306 of 837 in the Healthcare sector in United States, and Grid #2,033 of 4,000 in United States.
Which PosiPenta pillar is strongest for LENSAR, Inc.?
Torque (durability), with a score of 76 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for LENSAR, Inc.?
Price (valuation), with a score of 34 out of 100: weaker than most similar companies.
Has LENSAR, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.01 points, from 45.64 to 48.65.
PositoAI is for research and education only and is not investment advice.